Breast Cancer Research

Breast Cancer Research

Research into breast cancer at Penn State Cancer Institute is conducted by a dedicated breast cancer team. See current clinical trials and members of that team here.

Clinical Trials

Women In Steady Exercise Research - Neoadjuvant Exercise Trial
Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer (AMIE = Addressing Metastatic Individuals Everyday)
Impact of Prehabilitation in Oncology Via Exercise - Breast Cancer
Communication Preferences Related to Over Screening for Cancer Among Older Adults
Exercise in Radiation Therapy (EXERT)
Randomized Study of Patient Navigation for Women Diagnosed with Dense Breast Tissue on a Breast Cancer Screening Mammography
Phase II Palbociclib with Fulvestrant in Individuals with Hormone Receptive Positive HER2 Negative Metastatic Breast Cancer who progressed on treatment with Palbociclib + an Aromatase Inhibitor
CUFF Study: Characterization of Upper Limb Function following Mastectomy and Reconstruction for Breast Cancer
Physical Activity Training in Adolescents and Young Adults with Cancer: A Feasibility Study
Using Exercise to Improve Arthralgia and AI Adherence in Older Breast Cancer Survivors
Self-sampling for cancer tests among women in PA: Focus groups
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
The Effects of Inhaled Aromatherapy on Chemotherapy Induced Nausea and Vomiting (CINV) in Men and Women with Breast Cancer
Diminish Chemotherapy Related Side Effects through Patient Education
The COVID-19 and Cancer Consortium (CCC19) Registry
NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study
EA1181 (CompassHER2-pCR): Preoperative THP and postoperative HP in patients who achieve a pathologic complete response Part 1 Component of:The CompassHER2 Trials (COMprehensive use of Pathologic response Assessment to optimize therapy in HER2-positive breast cancer).
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
A Phase II, Single Arm, Non-randomized Study of Alpelisib (BYL719) in Combination with Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer Big Ten Cancer Research Consortium BTCRC-BRE19-409
COVID-19 Vaccination in Cancer Patients COVID-19 Vaccination Behavior and Outcomes in Cancer Patients
Clinicopathologic Study of Breast Cancer
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology
Research into breast cancer at Penn State Cancer Institute is conducted by a dedicated breast cancer team. See current clinical trials and members of that team here.
Women In Steady Exercise Research - Neoadjuvant Exercise Trial
Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer (AMIE = Addressing Metastatic Individuals Everyday)
Impact of Prehabilitation in Oncology Via Exercise - Breast Cancer
Communication Preferences Related to Over Screening for Cancer Among Older Adults
Exercise in Radiation Therapy (EXERT)
Randomized Study of Patient Navigation for Women Diagnosed with Dense Breast Tissue on a Breast Cancer Screening Mammography
Phase II Palbociclib with Fulvestrant in Individuals with Hormone Receptive Positive HER2 Negative Metastatic Breast Cancer who progressed on treatment with Palbociclib + an Aromatase Inhibitor
CUFF Study: Characterization of Upper Limb Function following Mastectomy and Reconstruction for Breast Cancer
Physical Activity Training in Adolescents and Young Adults with Cancer: A Feasibility Study
Using Exercise to Improve Arthralgia and AI Adherence in Older Breast Cancer Survivors
Self-sampling for cancer tests among women in PA: Focus groups
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
The Effects of Inhaled Aromatherapy on Chemotherapy Induced Nausea and Vomiting (CINV) in Men and Women with Breast Cancer
Diminish Chemotherapy Related Side Effects through Patient Education
The COVID-19 and Cancer Consortium (CCC19) Registry
NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study
EA1181 (CompassHER2-pCR): Preoperative THP and postoperative HP in patients who achieve a pathologic complete response Part 1 Component of:The CompassHER2 Trials (COMprehensive use of Pathologic response Assessment to optimize therapy in HER2-positive breast cancer).
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
A Phase II, Single Arm, Non-randomized Study of Alpelisib (BYL719) in Combination with Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer Big Ten Cancer Research Consortium BTCRC-BRE19-409
COVID-19 Vaccination in Cancer Patients COVID-19 Vaccination Behavior and Outcomes in Cancer Patients
Clinicopathologic Study of Breast Cancer
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)